- Home
- NRXP vs ANEB Comparison
NRXP vs ANEB Comparison
Compare NRXP & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- ANEB
- Stock Information
- Founded
- NRXP 2015
- ANEB 2020
- Country
- NRXP United States
- ANEB United States
- Employees
- NRXP N/A
- ANEB N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- NRXP Health Care
- ANEB Health Care
- Exchange
- NRXP Nasdaq
- ANEB Nasdaq
- Market Cap
- NRXP 32.6M
- ANEB 39.0M
- IPO Year
- NRXP N/A
- ANEB 2021
- Fundamental
- Price
- NRXP $3.02
- ANEB $1.89
- Analyst Decision
- NRXP Strong Buy
- ANEB Strong Buy
- Analyst Count
- NRXP 4
- ANEB 2
- Target Price
- NRXP $28.50
- ANEB $5.50
- AVG Volume (30 Days)
- NRXP 187.5K
- ANEB 23.5K
- Earning Date
- NRXP 08-13-2025
- ANEB 05-13-2025
- Dividend Yield
- NRXP N/A
- ANEB N/A
- EPS Growth
- NRXP N/A
- ANEB N/A
- EPS
- NRXP N/A
- ANEB N/A
- Revenue
- NRXP N/A
- ANEB N/A
- Revenue This Year
- NRXP N/A
- ANEB N/A
- Revenue Next Year
- NRXP N/A
- ANEB N/A
- P/E Ratio
- NRXP N/A
- ANEB N/A
- Revenue Growth
- NRXP N/A
- ANEB N/A
- 52 Week Low
- NRXP $1.10
- ANEB $0.80
- 52 Week High
- NRXP $6.01
- ANEB $3.08
- Technical
- Relative Strength Index (RSI)
- NRXP 43.71
- ANEB 65.41
- Support Level
- NRXP $2.89
- ANEB $1.53
- Resistance Level
- NRXP $3.53
- ANEB $1.85
- Average True Range (ATR)
- NRXP 0.15
- ANEB 0.30
- MACD
- NRXP -0.06
- ANEB -0.01
- Stochastic Oscillator
- NRXP 18.97
- ANEB 40.00
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.